Explore News By Topic


Prostate Cancer Foundation funded early research that underpinned test’s development

May 08, 2013—After men undergo a needle biopsy of their prostate gland and receive a positive diagnosis of cancer, they often face a difficult question: should they consent to aggressive therapy, with surgery or radiation, both of which may cause serious side effects such as sexual, bowel or bladder dysfunction, or... Read More


Stand Up To Cancer and Prostate Cancer Foundation Announce Second Research “Dream Team”

Up to $10 Million Grant Over Three Years will Fund Cutting-edge, Collaborative Research to Develop Personalized Treatments for Advanced Prostate Cancer "With generous support from Movember, PCF and its donors are pleased to team with Stand Up To Cancer to launch this unprecedented partnership for men with metastatic prostate cancer..."... Read More


PCF Young Investigators in Ireland are researching molecular differences between aggressive and low Gleason-grade cancers

http://player.vimeo.com/video/44534009 From its inception, PCF has focused heavily on investing in human capital, particularly in the form of young scientists with innovative approaches and tenacity. Our support of 125 young investigators around the world since 2008 underscores this commitment. One of the biggest challenges in diagnosing and treating the more... Read More


Prostate Cancer Foundation and Stand Up To Cancer Announce New Dream Team

April 01, 2012 -- The Prostate Cancer Foundation (PCF), Stand Up To Cancer (SU2C) and the American Association for Cancer Research (AACR), SU2C’s scientific partner, announced today the formation of a new Dream Team dedicated to prostate cancer research during a press conference at the AACR Annual Meeting 2012, held in... Read More